Sign In
Buy BNTX
$88.45
-0.690 (-0.774%)
At Close: Jun 03, 2026
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
10:03am, Wednesday, 05'th Mar 2025
A German court in Duesseldorf on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna.
U.S. FDA places clinical hold on BioNTech's malaria vaccine study
04:21pm, Tuesday, 04'th Mar 2025
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an early-to-mid stage trial of its malaria vaccine.
FDA Vaccine Panel Meeting To Discuss Flu Shots Reportedly Canceled
02:53am, Thursday, 27'th Feb 2025
A meeting of the Food and Drug Administration's vaccine advisory committee to discuss the next season's flu vaccine has reportedly been canceled, the second such disruption of a meeting involving vacc
Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus
09:30am, Monday, 24'th Feb 2025
Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.
BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025
06:45am, Monday, 24'th Feb 2025
MAINZ, Germany, February 24, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the fourth quarter and full year 2024 on
What Makes BioNTech (BNTX) a New Buy Stock
01:01pm, Thursday, 13'th Feb 2025
BioNTech (BNTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job
11:51am, Tuesday, 04'th Feb 2025
Shares of vaccine makers and packaged food companies fell on Tuesday after President Donald Trump's pick for U.S. health secretary, Robert F. Kennedy Jr., moved closer to the job after a favorable vot
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
11:50am, Tuesday, 04'th Feb 2025
Shares of vaccine companies fell after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services to the full chamber.
BioNTech Completes Acquisition of Biotheus
06:45am, Monday, 03'rd Feb 2025
MAINZ, Germany, February 3, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the completion of the acquisition of Biotheus (“Biotheus”),
3 Dirt-Cheap Stocks to Buy in a Market That's Priced for Perfection
04:52am, Wednesday, 22'nd Jan 2025
How expensive is the stock market right now? The S&P 500 Shiller CAPE ratio is near its second-highest level ever.
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know
10:56am, Friday, 17'th Jan 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in BioNTech (BNTX). While the effectiveness of this highly sought-after metric is questionable, the posit
BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
06:45am, Tuesday, 14'th Jan 2025
MAINZ, Germany, January 14, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today will present its 2025 strategic priorities and progress on the Company's p
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
06:10pm, Monday, 13'th Jan 2025
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
02:54pm, Friday, 10'th Jan 2025
On Thursday, Truist initiated coverage on BioNTech SE BNTX, a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc PFE.
BioNTech initiated with a Buy at Truist
08:49pm, Thursday, 09'th Jan 2025
Truist initiated coverage of BioNTech with a Buy rating and $172 price target. BioNTech is an oncology company "at heart, even though it was the COVID vaccine that made it a household name," the analy
